Role of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases

Purpose This was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer. Methods We searched the PubMed database for studies reporting detection of ctDNA in patients with colorectal cancer (CRC) and with peritoneal metastases (PM) from colorectal canc...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of gastrointestinal cancer Vol. 55; no. 1; pp. 41 - 46
Main Authors:	Baumgartner, Joel M., Botta, Gregory P.
Format:	Journal Article
Language:	English
Published:	New York Springer US 01.03.2024 Springer Nature B.V
Subjects:	Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Cancer Research Circulating Tumor DNA - blood Circulating Tumor DNA - genetics Colorectal Neoplasms - blood Colorectal Neoplasms - genetics Colorectal Neoplasms - pathology Gastroenterology Humans Internal Medicine Medicine Medicine & Public Health Neoplasm Recurrence, Local - blood Neoplasm Recurrence, Local - diagnosis Neoplasm Recurrence, Local - genetics Neoplasm Recurrence, Local - pathology Oncology Peritoneal Neoplasms - blood Peritoneal Neoplasms - diagnosis Peritoneal Neoplasms - genetics Peritoneal Neoplasms - secondary Prognosis Radiotherapy Review Peritoneal metastases ctDNA Colorectal cancer
ISSN:	1941-6628, 1941-6636, 1941-6636
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Purpose This was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer. Methods We searched the PubMed database for studies reporting detection of ctDNA in patients with colorectal cancer (CRC) and with peritoneal metastases (PM) from colorectal cancer (CRPM). We extracted data on the population included, number of subjects, study design, type of ctDNA assay used and schedule, and the major findings from these publications. Results We identified 13 studies for review investigating ctDNA, using a variety of ctDNA assays, among 1787 patients with CRC without PM, as well as four eligible published and one unpublished (in press) studies, which included 255 patients with PM from any primary site and 61 patients with CRPM. Among the 13 studies investigating ctDNA among CRC without PM, posttreatment surveillance ctDNA was associated with recurrence and was generally more sensitive than imaging or tumor markers. Among the five studies including patients with PM, ctDNA was not universally able to detect the presence of PM, but when present, ctDNA predicted worse outcomes. Conclusion Circulating-tumor DNA is a potentially useful surveillance tool for patients with CRC. However, the sensitivity of ctDNA to detect CRPM is variable and warrants further inquiry.
AbstractList	This was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer. We searched the PubMed database for studies reporting detection of ctDNA in patients with colorectal cancer (CRC) and with peritoneal metastases (PM) from colorectal cancer (CRPM). We extracted data on the population included, number of subjects, study design, type of ctDNA assay used and schedule, and the major findings from these publications. We identified 13 studies for review investigating ctDNA, using a variety of ctDNA assays, among 1787 patients with CRC without PM, as well as four eligible published and one unpublished (in press) studies, which included 255 patients with PM from any primary site and 61 patients with CRPM. Among the 13 studies investigating ctDNA among CRC without PM, posttreatment surveillance ctDNA was associated with recurrence and was generally more sensitive than imaging or tumor markers. Among the five studies including patients with PM, ctDNA was not universally able to detect the presence of PM, but when present, ctDNA predicted worse outcomes. Circulating-tumor DNA is a potentially useful surveillance tool for patients with CRC. However, the sensitivity of ctDNA to detect CRPM is variable and warrants further inquiry. Purpose This was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer. Methods We searched the PubMed database for studies reporting detection of ctDNA in patients with colorectal cancer (CRC) and with peritoneal metastases (PM) from colorectal cancer (CRPM). We extracted data on the population included, number of subjects, study design, type of ctDNA assay used and schedule, and the major findings from these publications. Results We identified 13 studies for review investigating ctDNA, using a variety of ctDNA assays, among 1787 patients with CRC without PM, as well as four eligible published and one unpublished (in press) studies, which included 255 patients with PM from any primary site and 61 patients with CRPM. Among the 13 studies investigating ctDNA among CRC without PM, posttreatment surveillance ctDNA was associated with recurrence and was generally more sensitive than imaging or tumor markers. Among the five studies including patients with PM, ctDNA was not universally able to detect the presence of PM, but when present, ctDNA predicted worse outcomes. Conclusion Circulating-tumor DNA is a potentially useful surveillance tool for patients with CRC. However, the sensitivity of ctDNA to detect CRPM is variable and warrants further inquiry. This was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer.PURPOSEThis was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer.We searched the PubMed database for studies reporting detection of ctDNA in patients with colorectal cancer (CRC) and with peritoneal metastases (PM) from colorectal cancer (CRPM). We extracted data on the population included, number of subjects, study design, type of ctDNA assay used and schedule, and the major findings from these publications.METHODSWe searched the PubMed database for studies reporting detection of ctDNA in patients with colorectal cancer (CRC) and with peritoneal metastases (PM) from colorectal cancer (CRPM). We extracted data on the population included, number of subjects, study design, type of ctDNA assay used and schedule, and the major findings from these publications.We identified 13 studies for review investigating ctDNA, using a variety of ctDNA assays, among 1787 patients with CRC without PM, as well as four eligible published and one unpublished (in press) studies, which included 255 patients with PM from any primary site and 61 patients with CRPM. Among the 13 studies investigating ctDNA among CRC without PM, posttreatment surveillance ctDNA was associated with recurrence and was generally more sensitive than imaging or tumor markers. Among the five studies including patients with PM, ctDNA was not universally able to detect the presence of PM, but when present, ctDNA predicted worse outcomes.RESULTSWe identified 13 studies for review investigating ctDNA, using a variety of ctDNA assays, among 1787 patients with CRC without PM, as well as four eligible published and one unpublished (in press) studies, which included 255 patients with PM from any primary site and 61 patients with CRPM. Among the 13 studies investigating ctDNA among CRC without PM, posttreatment surveillance ctDNA was associated with recurrence and was generally more sensitive than imaging or tumor markers. Among the five studies including patients with PM, ctDNA was not universally able to detect the presence of PM, but when present, ctDNA predicted worse outcomes.Circulating-tumor DNA is a potentially useful surveillance tool for patients with CRC. However, the sensitivity of ctDNA to detect CRPM is variable and warrants further inquiry.CONCLUSIONCirculating-tumor DNA is a potentially useful surveillance tool for patients with CRC. However, the sensitivity of ctDNA to detect CRPM is variable and warrants further inquiry. PurposeThis was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer.MethodsWe searched the PubMed database for studies reporting detection of ctDNA in patients with colorectal cancer (CRC) and with peritoneal metastases (PM) from colorectal cancer (CRPM). We extracted data on the population included, number of subjects, study design, type of ctDNA assay used and schedule, and the major findings from these publications.ResultsWe identified 13 studies for review investigating ctDNA, using a variety of ctDNA assays, among 1787 patients with CRC without PM, as well as four eligible published and one unpublished (in press) studies, which included 255 patients with PM from any primary site and 61 patients with CRPM. Among the 13 studies investigating ctDNA among CRC without PM, posttreatment surveillance ctDNA was associated with recurrence and was generally more sensitive than imaging or tumor markers. Among the five studies including patients with PM, ctDNA was not universally able to detect the presence of PM, but when present, ctDNA predicted worse outcomes.ConclusionCirculating-tumor DNA is a potentially useful surveillance tool for patients with CRC. However, the sensitivity of ctDNA to detect CRPM is variable and warrants further inquiry.
Author	Baumgartner, Joel M. Botta, Gregory P.
Author_xml	– sequence: 1 givenname: Joel M. orcidid: 0000-0001-5381-4751 surname: Baumgartner fullname: Baumgartner, Joel M. email: j1baumgartner@health.ucsd.edu organization: Division of Surgical Oncology, Department of Surgery, University of California – sequence: 2 givenname: Gregory P. surname: Botta fullname: Botta, Gregory P. organization: Division of Hematology-Oncology, Department of Medicine, University of California
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/37436640$$D View this record in MEDLINE/PubMed
BookMark	eNp9UU1v1TAQtFAr-gF_gAOKxIVLitd2HPuEnl75qNRCVZWz5SSbV1dOXGwHxL_H5bUFeqhkybv2zGh29oDszGFGQl4BPQJK23cJGGW6pozXlOpG1-oZ2QctoJaSy52Hmqk9cpDSNaVSNADPyR5vBZdS0H1ycRE8VmGs1i72i7fZzZvqcplCrI6_rKrVFEp_Xp5xzqn66fJVtQ4-ROyz9dU5RpeLqVKeYbapHEwvyO5ofcKXd_ch-fbxw-X6c3369dPJenVa96Jtcj0MUiDyMkPfSRgHa7kaOsE62QlJbZmqG5hgTHA-spZpHFsYVEfVQPkoQfBD8n6re7N0Ew59cRitNzfRTTb-MsE68__P7K7MJvwwAFRL0E1ReHunEMP3BVM2k0s9em9nDEsyTHHJNGigBfrmEfQ6LHEu8xnOGqG0ZAwK6vW_lh683OddAGoL6GNIKeJoepdLuuHWofMGqLldrdmu1pQQzJ_VGlWo7BH1Xv1JEt-SUgHPG4x_bT_B-g1cU7WH
CitedBy_id	crossref_primary_10_1002_dc_70009 crossref_primary_10_3390_cancers17091461 crossref_primary_10_4251_wjgo_v16_i11_4522 crossref_primary_10_1016_j_soc_2024_11_002 crossref_primary_10_1200_EDBK_25_481114 crossref_primary_10_1200_GO_24_00306 crossref_primary_10_1007_s12672_025_02435_0 crossref_primary_10_1038_s41568_024_00788_2 crossref_primary_10_1245_s10434_025_17363_0
Cites_doi	10.1371/journal.pmed.1003620 10.1093/annonc/mdz390 10.1093/annonc/mdv177 10.1016/j.ccell.2022.08.009 10.1007/978-1-4613-1247-5_4 10.1056/NEJMoa2200075 10.1001/jamaoncol.2019.0528 10.1245/s10434-014-3985-y 10.1007/s11547-016-0682-x 10.1056/NEJMoa2201445 10.1016/S1470-2045(20)30599-4 10.1038/s43018-020-0096-5 10.1016/S1470-2045(16)30500-9 10.1158/1078-0432.CCR-21-0410 10.1111/cas.14926 10.1001/jamaoncol.2019.3616 10.1038/nrc.2017.125 10.1007/s10585-020-10024-4 10.3322/caac.21708 10.1158/1078-0432.CCR-21-2404 10.1001/jamanetworkopen.2022.1100 10.1245/s10434-022-12399-y 10.1001/jamanetworkopen.2022.1093 10.1136/gutjnl-2017-315852 10.1245/s10434-018-6561-z 10.1245/s10434-020-08331-x 10.1038/nm.1789 10.1200/PO.21.00535 10.1056/NEJMra1706174 10.1126/scitranslmed.aaf6219 10.3390/jcm9061738 10.1200/PO.21.00101
ContentType	Journal Article
Copyright	This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 – notice: 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X7 7XB 8FI AFKRA BENPR CCPQU FYUFA M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM
DOI	10.1007/s12029-023-00959-8
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection ProQuest Central UK/Ireland ProQuest Central Database Suite (ProQuest) ProQuest One Community College Proquest Health Research Premium Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic ProQuest One Academic Middle East (New)
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X7 name: Health & Medical Collection (ProQuest) url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Anatomy & Physiology
EISSN	1941-6636
EndPage	46
ExternalDocumentID	PMC11096195 37436640 10_1007_s12029_023_00959_8
Genre	Journal Article Review
GroupedDBID	--- -5E -5G -BR -EM -Y2 -~C .VR 06C 06D 0R~ 0VY 1N0 203 29K 29~ 2J2 2JN 2JY 2KG 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5VS 6NX 8TC 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACCUX ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSNA ACUDM ACZOJ ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHSBF AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BDATZ BGNMA C6C CAG COF CS3 CSCUP D-I DDRTE DNIVK DPUIP EBLON EBS EIOEI EJD ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI H13 HF~ HG6 HMJXF HRMNR HZ~ IJ- IKXTQ IWAJR IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV LLZTM M4Y MA- N2Q N9A NPVJJ NQJWS NU0 O9- O9J OVD P9S PF0 PT4 QOK QOR R89 R9I ROL RSV S16 S1Z S27 S37 S3B SAP SCLPG SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 TEORI TSG TT1 TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR Z7U Z87 ZMTXR ZOVNA ~A9 ~KM 7X7 8FI AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFKRA AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA BENPR CCPQU CITATION FYUFA HMCUK M1P PHGZM PHGZT PJZUB PPXIY PSQYO UKHRP CGR CUY CVF ECM EIF NPM 7XB PKEHL PQEST PQQKQ PQUKI 7X8 5PM
ID	FETCH-LOGICAL-c475t-dd64ee3120cb61fdaa38db42b6b460a023bd2422433f2729ef71d8b08d03f6143
IEDL.DBID	RSV
ISICitedReferencesCount	12
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001026659000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1941-6628 1941-6636
IngestDate	Tue Nov 04 02:05:59 EST 2025 Thu Sep 04 19:32:23 EDT 2025 Tue Oct 07 07:08:19 EDT 2025 Mon Jul 21 06:01:08 EDT 2025 Tue Nov 18 21:58:50 EST 2025 Sat Nov 29 02:29:54 EST 2025 Fri Feb 21 02:40:28 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Peritoneal metastases ctDNA Colorectal cancer
Language	English
License	2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c475t-dd64ee3120cb61fdaa38db42b6b460a023bd2422433f2729ef71d8b08d03f6143
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
ORCID	0000-0001-5381-4751
OpenAccessLink	https://link.springer.com/10.1007/s12029-023-00959-8
PMID	37436640
PQID	3254896221
PQPubID	7435071
PageCount	6
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_11096195 proquest_miscellaneous_2836291910 proquest_journals_3254896221 pubmed_primary_37436640 crossref_citationtrail_10_1007_s12029_023_00959_8 crossref_primary_10_1007_s12029_023_00959_8 springer_journals_10_1007_s12029_023_00959_8
PublicationCentury	2000
PublicationDate	2024-03-01
PublicationDateYYYYMMDD	2024-03-01
PublicationDate_xml	– month: 03 year: 2024 text: 2024-03-01 day: 01
PublicationDecade	2020
PublicationPlace	New York
PublicationPlace_xml	– name: New York – name: United States
PublicationTitle	Journal of gastrointestinal cancer
PublicationTitleAbbrev	J Gastrointest Canc
PublicationTitleAlternate	J Gastrointest Cancer
PublicationYear	2024
Publisher	Springer US Springer Nature B.V
Publisher_xml	– name: Springer US – name: Springer Nature B.V
References	Baumgartner, Riviere, Lanman (CR27) 2020; 27 Franko, Shi, Meyers (CR3) 2016; 17 CR19 Reinert, Henriksen, Christensen (CR15) 2019; 5 CR17 Luskin, Murakami, Manalis, Weinstock (CR33) 2018; 18 Cercek, Lumish, Sinopoli (CR34) 2022; 386 CR11 CR32 Bando, Nakamura, Taniguchi (CR6) 2022; 6 Kastelein, Vos, van Baal (CR26) 2020; 37 Sullivan, Lo, Yu (CR31) 2023; 30 Siegel, Miller, Fuchs, Jemal (CR1) 2022; 72 CR30 Tie, Cohen, Wang (CR12) 2019; 68 Tarazona, Gimeno-Valiente, Gambardella (CR16) 2019; 30 Baumgartner, Raymond, Lanman (CR29) 2018; 25 Jacquet, Sugarbaker (CR24) 1996; 82 Taniguchi, Nakamura, Kotani (CR37) 2021; 112 Bratman, Yang, Iafolla (CR36) 2020; 1 Tie, Cohen, Wang (CR13) 2019; 5 Tie, Wang, Cohen (CR14) 2021; 18 CR2 Laghi, Bellini, Rengo (CR5) 2017; 122 Tie, Cohen, Lahouel (CR23) 2022; 386 Henriksen, Tarazona, Frydendahl (CR20) 2022; 28 Baumgartner, Tobin, Heavey, Kelly, Roeland, Lowy (CR28) 2015; 22 CR25 Tie, Kinde, Wang (CR10) 2015; 26 Diehl, Schmidt, Choti (CR9) 2008; 14 Chalabi (CR35) 2022; 40 Quénet, Elias, Roca (CR4) 2021; 22 Fakih, Sandhu, Wang (CR21) 2022; 5 Parikh, Van Seventer, Siravegna (CR18) 2021; 27 Venook (CR22) 2022; 5 Alese, Cook, Ortega-Franco, Ulanja, Tan, Tie (CR7) 2022; 42 Corcoran, Chabner (CR8) 2018; 379 J Tie (959_CR14) 2021; 18 959_CR2 JM Baumgartner (959_CR28) 2015; 22 M Fakih (959_CR21) 2022; 5 959_CR30 J Tie (959_CR23) 2022; 386 AW Kastelein (959_CR26) 2020; 37 A Laghi (959_CR5) 2017; 122 OB Alese (959_CR7) 2022; 42 J Tie (959_CR12) 2019; 68 959_CR19 A Cercek (959_CR34) 2022; 386 M Chalabi (959_CR35) 2022; 40 T Reinert (959_CR15) 2019; 5 JM Baumgartner (959_CR29) 2018; 25 959_CR11 TV Henriksen (959_CR20) 2022; 28 959_CR32 J Tie (959_CR10) 2015; 26 959_CR17 AR Parikh (959_CR18) 2021; 27 SV Bratman (959_CR36) 2020; 1 J Franko (959_CR3) 2016; 17 F Diehl (959_CR9) 2008; 14 H Taniguchi (959_CR37) 2021; 112 H Bando (959_CR6) 2022; 6 N Tarazona (959_CR16) 2019; 30 JM Baumgartner (959_CR27) 2020; 27 RL Siegel (959_CR1) 2022; 72 BG Sullivan (959_CR31) 2023; 30 RB Corcoran (959_CR8) 2018; 379 P Jacquet (959_CR24) 1996; 82 MR Luskin (959_CR33) 2018; 18 J Tie (959_CR13) 2019; 5 F Quénet (959_CR4) 2021; 22 AP Venook (959_CR22) 2022; 5 959_CR25
References_xml	– volume: 18 issue: 5 year: 2021 ident: CR14 article-title: Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: a prospective cohort study publication-title: PLoS Med doi: 10.1371/journal.pmed.1003620 – volume: 30 start-page: 1804 issue: 11 year: 2019 end-page: 1812 ident: CR16 article-title: Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdz390 – volume: 26 start-page: 1715 issue: 8 year: 2015 end-page: 1722 ident: CR10 article-title: Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdv177 – volume: 40 start-page: 914 issue: 9 year: 2022 end-page: 916 ident: CR35 article-title: Defying all odds in MMR-deficient rectal cancers publication-title: Cancer Cell doi: 10.1016/j.ccell.2022.08.009 – volume: 82 start-page: 53 year: 1996 end-page: 63 ident: CR24 article-title: Peritoneal-plasma barrier publication-title: Cancer Treat Res doi: 10.1007/978-1-4613-1247-5_4 – volume: 386 start-page: 2261 issue: 24 year: 2022 end-page: 2272 ident: CR23 article-title: Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa2200075 – ident: CR2 – ident: CR30 – volume: 5 start-page: 1124 issue: 8 year: 2019 end-page: 1131 ident: CR15 article-title: Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.0528 – volume: 22 start-page: 1716 issue: 5 year: 2015 end-page: 1721 ident: CR28 article-title: Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-3985-y – volume: 122 start-page: 1 issue: 1 year: 2017 end-page: 15 ident: CR5 article-title: Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis publication-title: Radiol Med doi: 10.1007/s11547-016-0682-x – volume: 386 start-page: 2363 issue: 25 year: 2022 end-page: 2376 ident: CR34 article-title: PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa2201445 – volume: 22 start-page: 256 issue: 2 year: 2021 end-page: 266 ident: CR4 article-title: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(20)30599-4 – volume: 42 start-page: 1 year: 2022 end-page: 20 ident: CR7 article-title: Circulating tumor DNA: an emerging tool in gastrointestinal cancers publication-title: Am Soc Clin Oncol Educ Book – ident: CR25 – volume: 1 start-page: 873 issue: 9 year: 2020 end-page: 881 ident: CR36 article-title: Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab publication-title: Nat Cancer doi: 10.1038/s43018-020-0096-5 – volume: 17 start-page: 1709 issue: 12 year: 2016 end-page: 1719 ident: CR3 article-title: Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database publication-title: Lancet Oncol doi: 10.1016/S1470-2045(16)30500-9 – volume: 27 start-page: 5586 issue: 20 year: 2021 end-page: 5594 ident: CR18 article-title: Minimal residual disease detection using a plasma-only circulating tumor DNA assay in patients with colorectal cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-21-0410 – volume: 112 start-page: 2915 issue: 7 year: 2021 end-page: 2920 ident: CR37 article-title: CIRCULATE-Japan: circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer publication-title: Cancer Sci doi: 10.1111/cas.14926 – ident: CR19 – volume: 5 start-page: 1710 issue: 12 year: 2019 end-page: 1717 ident: CR13 article-title: Circulating Tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.3616 – volume: 18 start-page: 255 issue: 4 year: 2018 end-page: 263 ident: CR33 article-title: Targeting minimal residual disease: a path to cure? publication-title: Nat Rev Cancer doi: 10.1038/nrc.2017.125 – volume: 37 start-page: 293 issue: 2 year: 2020 end-page: 304 ident: CR26 article-title: Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer publication-title: Clin Exp Metastasis doi: 10.1007/s10585-020-10024-4 – volume: 72 start-page: 7 issue: 1 year: 2022 end-page: 33 ident: CR1 article-title: Cancer statistics, 2022 publication-title: CA Cancer J Clin doi: 10.3322/caac.21708 – volume: 28 start-page: 507 issue: 3 year: 2022 end-page: 517 ident: CR20 article-title: Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, toward assessment of adjuvant therapy efficacy and clinical behavior of recurrences publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-21-2404 – ident: CR17 – volume: 5 start-page: e221100 issue: 3 year: 2022 end-page: e221100 ident: CR22 article-title: Colorectal cancer surveillance with circulating tumor DNA assay publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2022.1100 – volume: 30 start-page: 278 issue: 1 year: 2023 end-page: 284 ident: CR31 article-title: Circulating tumor DNA is unreliable to detect somatic gene alterations in gastrointestinal peritoneal carcinomatosis publication-title: Ann Surg Oncol doi: 10.1245/s10434-022-12399-y – ident: CR11 – volume: 5 start-page: e221093 issue: 3 year: 2022 end-page: e221093 ident: CR21 article-title: Evaluation of comparative surveillance strategies of circulating tumor DNA, imaging, and carcinoembryonic antigen levels in patients with resected colorectal cancer publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2022.1093 – volume: 68 start-page: 663 issue: 4 year: 2019 end-page: 671 ident: CR12 article-title: Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study publication-title: Gut doi: 10.1136/gutjnl-2017-315852 – volume: 25 start-page: 2400 issue: 8 year: 2018 end-page: 2408 ident: CR29 article-title: Preoperative circulating tumor DNA in patients with peritoneal carcinomatosis is an independent predictor of progression-free survival publication-title: Ann Surg Oncol doi: 10.1245/s10434-018-6561-z – ident: CR32 – volume: 27 start-page: 3259 issue: 9 year: 2020 end-page: 3267 ident: CR27 article-title: Prognostic utility of pre- and postoperative circulating tumor DNA liquid biopsies in patients with peritoneal metastases publication-title: Ann Surg Oncol doi: 10.1245/s10434-020-08331-x – volume: 14 start-page: 985 issue: 9 year: 2008 end-page: 990 ident: CR9 article-title: Circulating mutant DNA to assess tumor dynamics publication-title: Nat Med doi: 10.1038/nm.1789 – volume: 6 year: 2022 ident: CR6 article-title: Effects of metastatic sites on circulating tumor DNA in patients with metastatic colorectal cancer publication-title: JCO Precis Oncol doi: 10.1200/PO.21.00535 – volume: 379 start-page: 1754 issue: 18 year: 2018 end-page: 1765 ident: CR8 article-title: Application of cell-free DNA analysis to cancer treatment publication-title: N Engl J Med doi: 10.1056/NEJMra1706174 – ident: 959_CR11 doi: 10.1126/scitranslmed.aaf6219 – volume: 5 start-page: e221093 issue: 3 year: 2022 ident: 959_CR21 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2022.1093 – volume: 72 start-page: 7 issue: 1 year: 2022 ident: 959_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21708 – volume: 18 issue: 5 year: 2021 ident: 959_CR14 publication-title: PLoS Med doi: 10.1371/journal.pmed.1003620 – volume: 112 start-page: 2915 issue: 7 year: 2021 ident: 959_CR37 publication-title: Cancer Sci doi: 10.1111/cas.14926 – ident: 959_CR30 doi: 10.3390/jcm9061738 – volume: 379 start-page: 1754 issue: 18 year: 2018 ident: 959_CR8 publication-title: N Engl J Med doi: 10.1056/NEJMra1706174 – volume: 6 year: 2022 ident: 959_CR6 publication-title: JCO Precis Oncol doi: 10.1200/PO.21.00535 – volume: 82 start-page: 53 year: 1996 ident: 959_CR24 publication-title: Cancer Treat Res doi: 10.1007/978-1-4613-1247-5_4 – volume: 1 start-page: 873 issue: 9 year: 2020 ident: 959_CR36 publication-title: Nat Cancer doi: 10.1038/s43018-020-0096-5 – volume: 386 start-page: 2363 issue: 25 year: 2022 ident: 959_CR34 publication-title: N Engl J Med doi: 10.1056/NEJMoa2201445 – volume: 26 start-page: 1715 issue: 8 year: 2015 ident: 959_CR10 publication-title: Ann Oncol doi: 10.1093/annonc/mdv177 – volume: 386 start-page: 2261 issue: 24 year: 2022 ident: 959_CR23 publication-title: N Engl J Med doi: 10.1056/NEJMoa2200075 – ident: 959_CR19 doi: 10.1200/PO.21.00101 – volume: 40 start-page: 914 issue: 9 year: 2022 ident: 959_CR35 publication-title: Cancer Cell doi: 10.1016/j.ccell.2022.08.009 – volume: 68 start-page: 663 issue: 4 year: 2019 ident: 959_CR12 publication-title: Gut doi: 10.1136/gutjnl-2017-315852 – volume: 18 start-page: 255 issue: 4 year: 2018 ident: 959_CR33 publication-title: Nat Rev Cancer doi: 10.1038/nrc.2017.125 – volume: 122 start-page: 1 issue: 1 year: 2017 ident: 959_CR5 publication-title: Radiol Med doi: 10.1007/s11547-016-0682-x – volume: 22 start-page: 1716 issue: 5 year: 2015 ident: 959_CR28 publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-3985-y – volume: 5 start-page: 1124 issue: 8 year: 2019 ident: 959_CR15 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.0528 – volume: 25 start-page: 2400 issue: 8 year: 2018 ident: 959_CR29 publication-title: Ann Surg Oncol doi: 10.1245/s10434-018-6561-z – volume: 27 start-page: 3259 issue: 9 year: 2020 ident: 959_CR27 publication-title: Ann Surg Oncol doi: 10.1245/s10434-020-08331-x – volume: 37 start-page: 293 issue: 2 year: 2020 ident: 959_CR26 publication-title: Clin Exp Metastasis doi: 10.1007/s10585-020-10024-4 – volume: 14 start-page: 985 issue: 9 year: 2008 ident: 959_CR9 publication-title: Nat Med doi: 10.1038/nm.1789 – volume: 5 start-page: e221100 issue: 3 year: 2022 ident: 959_CR22 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2022.1100 – ident: 959_CR25 – volume: 22 start-page: 256 issue: 2 year: 2021 ident: 959_CR4 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(20)30599-4 – ident: 959_CR17 – volume: 17 start-page: 1709 issue: 12 year: 2016 ident: 959_CR3 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(16)30500-9 – volume: 27 start-page: 5586 issue: 20 year: 2021 ident: 959_CR18 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-21-0410 – volume: 42 start-page: 1 year: 2022 ident: 959_CR7 publication-title: Am Soc Clin Oncol Educ Book – volume: 30 start-page: 1804 issue: 11 year: 2019 ident: 959_CR16 publication-title: Ann Oncol doi: 10.1093/annonc/mdz390 – ident: 959_CR32 – ident: 959_CR2 – volume: 28 start-page: 507 issue: 3 year: 2022 ident: 959_CR20 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-21-2404 – volume: 5 start-page: 1710 issue: 12 year: 2019 ident: 959_CR13 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.3616 – volume: 30 start-page: 278 issue: 1 year: 2023 ident: 959_CR31 publication-title: Ann Surg Oncol doi: 10.1245/s10434-022-12399-y
SSID	ssj0064511
Score	2.4072878
SecondaryResourceType	review_article
Snippet	Purpose This was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer. Methods We searched the PubMed... This was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer. We searched the PubMed database for studies... PurposeThis was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer.MethodsWe searched the PubMed database... This was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer.PURPOSEThis was a review of circulating tumor...
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	41
SubjectTerms	Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Cancer Research Circulating Tumor DNA - blood Circulating Tumor DNA - genetics Colorectal Neoplasms - blood Colorectal Neoplasms - genetics Colorectal Neoplasms - pathology Gastroenterology Humans Internal Medicine Medicine Medicine & Public Health Neoplasm Recurrence, Local - blood Neoplasm Recurrence, Local - diagnosis Neoplasm Recurrence, Local - genetics Neoplasm Recurrence, Local - pathology Oncology Peritoneal Neoplasms - blood Peritoneal Neoplasms - diagnosis Peritoneal Neoplasms - genetics Peritoneal Neoplasms - secondary Prognosis Radiotherapy Review
SummonAdditionalLinks	– databaseName: Health & Medical Collection (ProQuest) dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagcODCqzwCBRkJcYEIv-I4J7RaqLiwWlVF2lsUP0JXapOy2a3Uf8-Mk81qqeiFWyTHcpwZe74Zj78h5D0THqyGD6kzmUlVwU1qs4AXgXMWalcjM24sNpHPZmaxKOZDwK0b0iq3e2LcqH3rMEb-WYInYwotBP9y-TvFqlF4ujqU0LhL7mHZbOTOzxejw6WReyueKiueai3McGmmvzonMPEDLFbK-lDYvmG6gTZvJk3-dXIaDdLxo_-dymPycICidNLrzhNyJzRPyeGkATf84pp-oDE5NEbdD8nJSXseaFvT6XLlYsWv5hc93Vy0K_p1NqETLFlE5z1Ha0cxuEun0BW3UxhiDmqOpN_w-COsKwCkXeiekZ_H306n39OhHEPqVJ6tU--1CkHCj3NW89pXlTTeKmG1VZpV8CutB4MvlJS1AMwe6px7Y5nxTNaAAuRzctDAWC8JzTPAkbC5gCJw5QAEMWaZA32SlntZ8ITwrSxKN3CVY8mM83LHsozyK2HQMsqvNAn5OPa57Jk6bn37aCubcli1XbkTTELejc2w3vAQpWpCu-lKgGNaFODlsoS86DViHE4CHNNaQYvZ05XxBeTy3m9plmeR0xuJX8GXzRLyaatWu-_69zRe3T6N1-QB9FB9ztwROVivNuENue-u1stu9TYulj_tLxgg priority: 102 providerName: ProQuest
Title	Role of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases
URI	https://link.springer.com/article/10.1007/s12029-023-00959-8 https://www.ncbi.nlm.nih.gov/pubmed/37436640 https://www.proquest.com/docview/3254896221 https://www.proquest.com/docview/2836291910 https://pubmed.ncbi.nlm.nih.gov/PMC11096195
Volume	55
WOSCitedRecordID	wos001026659000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Health & Medical Collection (ProQuest) customDbUrl: eissn: 1941-6636 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0064511 issn: 1941-6628 databaseCode: 7X7 dateStart: 20230301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1941-6636 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0064511 issn: 1941-6628 databaseCode: BENPR dateStart: 20230301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink customDbUrl: eissn: 1941-6636 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0064511 issn: 1941-6628 databaseCode: RSV dateStart: 20070101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-xDSFegG18FLbKSNNeIJJjO47zWMqmvayqyjb1LYo_ApW2FDUtEv89ZydpVQZI7CWKYsfnj7Pv7Dv_DuCEMotSw7rIqERFIotVpBPnLwKn1JWm9Mi4IdhEOhqp6TQbt5fC6s7bvTNJhpV6c9mNeVcNlDERbQ6vdmAPxZ3y03Hy5aZbf6VH3Aq2ZBFHUjLVXpX5cxnb4uiejnnfVfI3e2kQQ-fPH9aAF_CsVTvJoOGTfXjkqgM4HFS45b77SU5JcAQNJ-wH8OSytbcfwmQyv3VkXpLhbGFCoK_qK7la3c0X5PNoQAY-UhEZN9CsNfFnumSIpfhVFKmNkbs91je-XrplgXpo7eqXcH1-djW8iNooDJERabKMrJXCOY6VN1rGpS0KrqwWTEstJC2wOdqinGeC85Khqu7KNLZKU2UpL1H481ewWyGtN0DSBNVHXFNw_GNhUPehVFODbMR1bHkW9yDuBiM3LUS5j5Rxm2_AlX0f5kg0D32Yqx58WP_zvQHo-Gfuo26M83ay1jnHTbLKJGNYgffrZJxm3nZSVG6-qnPUwiTLcHNLe_C6YYk1OY5amJQCU9QWs6wzeAjv7ZRq9i1AeXu8V9zCJj342PHMpl5_b8bb_8v-Dp7iJ9G4zh3B7nKxcsfw2PxYzupFH3bSaRqeqg97n85G40k_zKhfbHkU4g
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VggQXXuURKGAk4AIRfiSOc0BotaVq1Xa1qhZpb2kSO7BSm5RNFtQ_xW9k7CS7Wip664FbJMdxnHyeh2f8DcAbyjVqDW38XIXKD2Km_Cw09iBwRE2RF5YZ1xWbiEYjNZ3G4w343Z-FsWmVvUx0glpXud0j_yjQk1Gx5Jx9Pv_h26pRNrral9BoYXFgLn6hy1Z_2t_B__uW890vk-Ge31UV8PMgChtfaxkYIxineSZZodNUKJ0FPJNZIGmKOizTqLd4IETB0fQ0RcS0yqjSVBSozAQ-9wbcRDke2RSyaLp08KTl-nJR7ID5UnLVHdJpj-pxm2iCT_dpu_W2rggvWbeXkzT_itQ6Bbh773_7dPfhbmdqk0G7Nh7AhikfwtagTJvq7IK8Iy751UUVtuD4uDo1pCrIcDbPXUWz8huZLM6qOdkZDcjAlmQi45aDtiZ285oMsatVFzjEGJexJTXHyyPTpGhw16Z-BF-vZXaPYbPEsZ4CiUK0k1F4ItBZkKORR2lGc1wvImNaxMwD1v_7JO-42G1JkNNkxSJt8ZLgoInDS6I8eL_sc94ykVx593aPhaSTSnWyAoIHr5fNKE9skCgtTbWoEzQ3JY_Ri6cePGkRuBxOoLkpZYAtag2byxssV_l6Szn77jjLLbEt-uqhBx96GK_e69_TeHb1NF7B7b3J0WFyuD86eA53sHfQ5gduw2YzX5gXcCv_2czq-Uu3UAmcXDe8_wDMuHRf
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_BQNNe-NjYKAwwEuIFojmx4ziPVUcFglXVGGhvVvwRqLSlU5Mi8d9zdpKWMkBCvFWyG9vJ2fc7393vAF7QxKLWsC4yMpURz2MZ6dT5ROCMutKUnhk3FJvIJhN5fp5Pf8riD9HuvUuyzWnwLE1Vc3Rly6N14lviwzZQ30S0vci6Cbe4Lxrk7fWPn_uzWHj2reBX5nEkRCK7tJnfP2NTNV3Dm9fDJn_xnQaVNL77_4u5B3c6OEqGrfzchxuu2oW9YYWm-OV38pKEANFw874L2yedH34PTk_nF47MSzKaLUwoAFZ9IWfLy_mCHE-GZOgrGJFpS9laE3_XS0b4FH-64mhTlHrPAY4_T1xTID6tXf0APo3fnI3eRl11hsjwLG0iawV3juHkjRZxaYuCSat5ooXmgha4HG1R_yecsTJBCO_KLLZSU2kpKxEUsH3YqnCsh0CyFGElnjUoFzE3iIko1dSgeDEdW5bHA4j7D6NMR13uK2hcqDXpsn-HCgdV4R0qOYBXq_9ctcQdf-192H9v1W3iWjE0nmUukgQn8HzVjNvP-1SKys2XtUJ0JpIcjV46gINWPFbDMURnQnBskRuCs-rgqb03W6rZ10Dx7Xlg0bRNB_C6l5_1vP68jEf_1v0ZbE-Px-rDu8n7x7CDrbyNrjuErWaxdE_gtvnWzOrF07CpfgDHyh1B
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+Circulating+Tumor+DNA+Among+Patients+with+Colorectal+Peritoneal+Metastases&rft.jtitle=Journal+of+gastrointestinal+cancer&rft.au=Baumgartner%2C+Joel+M.&rft.au=Botta%2C+Gregory+P.&rft.date=2024-03-01&rft.issn=1941-6628&rft.eissn=1941-6636&rft.volume=55&rft.issue=1&rft.spage=41&rft.epage=46&rft_id=info:doi/10.1007%2Fs12029-023-00959-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s12029_023_00959_8
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1941-6628&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1941-6628&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1941-6628&client=summon